# Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

> **NCT02017964** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 26 (actual)

## Conditions studied

- Desmoplastic/Nodular Medulloblastoma
- Medulloblastoma
- Medulloblastoma With Extensive Nodularity
- Nevoid Basal Cell Carcinoma Syndrome

## Interventions

- **DRUG:** Carboplatin
- **OTHER:** Cognitive Assessment
- **DRUG:** Cyclophosphamide
- **DRUG:** Etoposide
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Methotrexate
- **DRUG:** Vincristine Sulfate

## Key facts

- **NCT ID:** NCT02017964
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-24
- **Primary completion:** 2018-03-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017964, "Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02017964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*